Taiwan FDA registration 363068c39d695d065dc40e757b0099db
LIAISON Multi-Control Tumour Markers
TW: 禮雅尚多重腫瘤標記品管物質組
Taiwan·Risk Class 2·MD·DIASORIN ITALIA S.P.A.·Registered Feb 27, 2018 – Feb 27, 2028ActiveRegistration details
- Analysis ID
- 363068c39d695d065dc40e757b0099db
- License Form
- Ministry of Health Medical Device Import No. 030512
- Customs Code
- DHA05603051201
Company information
- Manufacturer
- DIASORIN ITALIA S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- MEDRICH INSTRUMENT CO., LTD.
Product details
- Intended Use
- This product is designed to provide reliability in the analysis of tumor markers (AFP, CA 125 II, CA 15-3, CA 19-9, CEA, Ferritin, HCG and β2-Microglobulin) in serum by LIAISON and LIAISON XL automated immunofluorescence analyzers.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Feb 27, 2018
- Expiry Date
- Feb 27, 2028
About this record
Access comprehensive regulatory information for LIAISON Multi-Control Tumour Markers in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 363068c39d695d065dc40e757b0099db and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is MEDRICH INSTRUMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices